日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Optimal dose of maintenance steroid therapy for relapse of chronic eosinophilic pneumonia: a multicentre retrospective study

慢性嗜酸性肺炎复发维持性激素治疗的最佳剂量：一项多中心回顾性研究

期刊:Bmj Open Respiratory Research
影响因子:3.4
doi:10.1136/bmjresp-2024-002697
Atsumi, Kenichiro; Nishima, Shunichi; Tanaka, Toru; Kamio, Koichiro; Taniuchi, Namiko; Saito, Yoshinobu; Shimizu, Masamitsu; Okano, Tetsuya; Seike, Masahiro; Hirose, Takashi
肺炎
免疫/内分泌
发表日期：2025
文献求助 收藏

Safety and Efficacy of Gefitinib Administration After Osimertinib-Induced Interstitial Lung Disease: A Six-Case Series

吉非替尼治疗奥希替尼诱发间质性肺病的安全性和有效性：六例病例系列研究

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S475836
Shimbu, Kaoruko; Hisakane, Kakeru; Kadoma, Naohiro; Nishima, Shunichi; Atsumi, Kenichiro; Seike, Masahiro; Hirose, Takashi
特发性肺纤维化
发表日期：2024
文献求助 收藏

Bortezomib induces Rho-dependent hyperpermeability of endothelial cells synergistically with inflammatory mediators.

硼替佐米与炎症介质协同诱导内皮细胞Rho依赖性高通透性

期刊:BMC Pulmonary Medicine
影响因子:2.8
doi:10.1186/s12890-024-03387-x
Nishima Shunichi, Kashiwada Takeru, Saito Yoshinobu, Yuge Shinya, Ishii Tomohiro, Matsuda Kuniko, Kamio Koichiro, Seike Masahiro, Fukuhara Shigetomo, Gemma Akihiko
细胞生物学
炎症
发表日期：2024
文献求助 收藏

Novel evaluation of pulmonary hypertension associated with chronic lung disease using perfusion SPECT/CT: A pilot study

利用灌注SPECT/CT对慢性肺病相关肺动脉高压进行新型评估：一项初步研究

期刊:Pulmonary Circulation
影响因子:2.5
doi:10.1002/pul2.12423
Atsumi, Kenichiro; Fukushima, Yoshimitsu; Tanaka, Yosuke; Nishima, Shunichi; Tanaka, Toru; Seike, Masahiro; Kubota, Yoshiaki; Kimura, Hiroshi
肺动脉高压
心血管
发表日期：2024
文献求助 收藏

Evaluation of sarcoidosis with multiple bone lesions using both bone scintigraphy and FDG-PET/CT: A case report

应用骨扫描和FDG-PET/CT评估伴有多发性骨病变的结节病：病例报告

期刊:Respiratory Medicine Case Reports
影响因子:0.7
doi:10.1016/j.rmcr.2024.102077
Kadoma, Naohiro; Atsumi, Kenichiro; Shinbu, Kaoruko; Nishima, Shunichi; Hisakane, Kakeru; Nagata, Koji; Seike, Masahiro; Hirose, Takashi
发表日期：2024
文献求助 收藏

Remarkable Clinical Response of ALK-Rearranged/TP53-Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report

ALK重排/TP53突变型肺腺癌伴肝转移患者在接受ALK抑制剂治疗后，接受阿特珠单抗-贝伐珠单抗-卡铂-紫杉醇联合化疗方案治疗，临床疗效显著：病例报告

期刊:Oncotargets and Therapy
影响因子:2.8
doi:10.2147/OTT.S404035
Iso, Hirokazu; Miyanaga, Akihiko; Kadoma, Naohiro; Shinbu, Kaoruko; Tozuka, Takehiro; Murata, Akari; Nishima, Shunichi; Sato, Yozo; Nakamichi, Shinji; Matsumoto, Masaru; Noro, Rintaro; Terasaki, Yasuhiro; Kubota, Kaoru; Seike, Masahiro
ALK
肿瘤
P53
肿瘤免疫
发表日期：2023
文献求助 收藏

Successful Treatment with Afatinib after Osimertinib-induced Interstitial Lung Disease in a Patient with EGFR-mutant Non-small-cell Lung Cancer

阿法替尼成功治疗EGFR突变型非小细胞肺癌患者奥希替尼诱发的间质性肺病

期刊:Internal Medicine
影响因子:1.1
doi:10.2169/internalmedicine.5435-20
Nishima, Shunichi; Miyanaga, Akihiko; Saito, Sho; Yuasa, Mizuki; Takahashi, Satoshi; Kashiwada, Takeru; Sugano, Teppei; Noro, Rintaro; Minegishi, Yuji; Terasaki, Yasuhiro; Saito, Yoshinobu; Kubota, Kaoru; Seike, Masahiro; Gemma, Akihiko
肺癌
肿瘤
特发性肺纤维化
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2021
文献求助 收藏